Correction: Efficacy and safety in a 4-year follow-up of the ELEVATE-TN study comparing acalabrutinib with or without obinutuzumab versus obinutuzumab plus chlorambucil in treatment-naïve chronic lymphocytic leukemia

• 期刊论文

• 出版模式：

  开放获取

• 发表日期：

  2024年12月3日

• Jeff P. Sharman,
• Miklos Egyed,
• Wojciech Jurczak,
• Alan Skarbnik,
• John M. Pagel,
• Ian W. Flinn,
• Manali Kamdar,
• Talha Munir,
• Renata Walewska,
• Gillian Corbett,
• Laura Maria Fogliatto,
• Yair Herishanu,
• Versha Banerji,
• Steven Coutre,
• George Follows,
• Patricia Walker,
• Karin Karlsson,
• Paolo Ghia,
• Ann Janssens,
• Florence Cymbalista,
• Jennifer A. Woyach,
• Emmanuelle Ferrant,
• William G. Wierda,
• Veerendra Munugalavadla,
• Ting Yu,
• Min Hui Wang,
• John C. Byrd